Daniel Muliaditan
@dmuliaditan.bsky.social
Scientist at the Genome Institute Singapore (GIS), Agency of Science, Technology and Research (A*STAR). I work on cancer genomics, with a focus on the role of focal amplifications in squamous carcinoma.
Reposted by Daniel Muliaditan
We are looking for our next PhD student to join us 🤩 www.mcclellandlab.com to understand cancer radiation therapy's impact on DNA damage repair and chromosomal instability. Prestigious funding from CRUK RadNet. Please contact me informally - deadline 5th Nov! crukradnet.colcc.ac.uk/phd-students...
October 2, 2025 at 3:49 PM
We are looking for our next PhD student to join us 🤩 www.mcclellandlab.com to understand cancer radiation therapy's impact on DNA damage repair and chromosomal instability. Prestigious funding from CRUK RadNet. Please contact me informally - deadline 5th Nov! crukradnet.colcc.ac.uk/phd-students...
Reposted by Daniel Muliaditan
Come and join us at the Barts Cancer Institute @qmbci.bsky.social ! Our medical school, part of Queen Mary University of London @qmulfmd.bsky.social is hiring 10 professors!! www.veredus.co.uk/job/job-747a/. Contact me for a chat if interested.
Professors x 10, Faculty of Medicine & Dentistry | Veredus
QUEEN MARY UNIVERSITY OF LONDON Professors x 10, Faculty of Medicine and Dentistry London Competitive Remuneration Package Queen Mary University of London seeks up to 10 world-leading translational re...
www.veredus.co.uk
October 1, 2025 at 7:34 AM
Come and join us at the Barts Cancer Institute @qmbci.bsky.social ! Our medical school, part of Queen Mary University of London @qmulfmd.bsky.social is hiring 10 professors!! www.veredus.co.uk/job/job-747a/. Contact me for a chat if interested.
Reposted by Daniel Muliaditan
Happy to post our first preprint in a while! www.biorxiv.org/content/10.1.... This was a slightly new direction for us, spearheaded by amazing post-doc @audreylumeau.bsky.social. Short thread to follow 🧬
March 7, 2025 at 4:54 PM
Happy to post our first preprint in a while! www.biorxiv.org/content/10.1.... This was a slightly new direction for us, spearheaded by amazing post-doc @audreylumeau.bsky.social. Short thread to follow 🧬
Reposted by Daniel Muliaditan
Making my first post on Bluesky to share an exciting new paper. Not all focal oncogene amplifications are the same! Really great work led by Siavash Raeisi Dehkordi in the Bafna lab.
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Breakage fusion bridge cycles drive high oncogene number with moderate intratumoural heterogeneity - Nature Communications
The impact of breakage fusion bridge (BFB) cycles on tumour heterogeneity and clinical outcomes remains poorly understood. Here, the authors develop OM2BFB, an algorithm to detect and reconstruct BFB ...
www.nature.com
February 12, 2025 at 12:53 AM
Making my first post on Bluesky to share an exciting new paper. Not all focal oncogene amplifications are the same! Really great work led by Siavash Raeisi Dehkordi in the Bafna lab.
www.nature.com/articles/s41...
www.nature.com/articles/s41...